- Report
- April 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- April 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- March 2025
- 175 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- June 2024
- 309 Pages
Global
From €3205EUR$3,500USD£2,729GBP
€4579EUR$5,000USD£3,899GBP
- Report
- May 2025
- 383 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 289 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 193 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 202 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- May 2025
- 369 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- February 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- April 2025
- 185 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- July 2024
- 118 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- April 2025
- 120 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- July 2024
- 150 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- July 2024
- 100 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- November 2024
- 297 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- August 2024
- 168 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- August 2024
- 200 Pages
Global
From €3543EUR$3,869USD£3,017GBP
- Report
- May 2024
- 127 Pages
Global
From €4575EUR$4,995USD£3,895GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3543EUR$3,869USD£3,017GBP

The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more